Catherine Simcock

Catherine Simcock has a diverse work experience in the clinical research field. Catherine recently served as the Director of Clinical Operations at Liminal BioSciences, starting in May 2022. Prior to that, they worked as the Senior Manager of Clinical Affairs at the same company from November 2017 to April 2022. Catherine also held the role of AD, Clinical Operations Lead at Convergence Pharmaceuticals Ltd. (a Biogen Company) from February 2015 to October 2017. Catherine gained extensive experience at Gilead Sciences as a Clinical Program Manager from November 2008 to January 2015. Catherine also served as the PM, COM and Operations Director at Harrison Clinical Research (now SynteractHCR) from May 2004 to April 2008. Catherine worked briefly as a Director at LION Clinical Research Management Ltd in 2008. Catherine started their career at PPD as an Assistant COM and Clinical Trial Manager from August 1998 to April 2004. Catherine also worked at AstraZeneca as a CRA and Senior CRA from 1994 to 1998 and at Hoffmann-La Roche as an Intern in Regulatory Affairs and CRA from 1990 to 1994.

Catherine Simcock completed their Bachelor of Pharmacy degree at the University of the Witwatersrand from 1984 to 1990. No further information is provided about their field of study during this time.